Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories… Read more
Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.075x
Based on the latest financial reports, Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) has a cash flow conversion efficiency ratio of 0.075x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€17.59 Million) by net assets (€233.15 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Eckert & Ziegler Strahlen- und Medizintechnik AG - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Eckert & Ziegler Strahlen- und Medizintechnik AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Eckert & Ziegler Strahlen- und Medizintechnik AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eckert & Ziegler Strahlen- und Medizintechnik AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Liquidity Services Inc
NASDAQ:LQDT
|
-0.002x |
|
Beijing Utour International Travel Service Co Ltd
SHE:002707
|
0.154x |
|
Yijiahe Technology Co Ltd
SHG:603666
|
-0.030x |
|
Hubei Zhongyi Science Technology Co. Ltd.
SHE:301150
|
0.004x |
|
Adrian Resources Ltd
PINK:ADLRF
|
-0.064x |
|
Southern Publishing&Media Co
SHG:601900
|
0.007x |
|
ARIAKE JAPAN CO.LTD
F:5EF
|
N/A |
|
NioCorp Developments Ltd. Common Stock
NASDAQ:NB
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Eckert & Ziegler Strahlen- und Medizintechnik AG (2013–2024)
The table below shows the annual cash flow conversion efficiency of Eckert & Ziegler Strahlen- und Medizintechnik AG from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €225.21 Million | €66.57 Million | 0.296x | +39.76% |
| 2023-12-31 | €224.09 Million | €47.40 Million | 0.212x | +31.74% |
| 2022-12-31 | €213.63 Million | €34.30 Million | 0.161x | -8.70% |
| 2021-12-31 | €192.53 Million | €33.85 Million | 0.176x | -25.07% |
| 2020-12-31 | €148.92 Million | €34.95 Million | 0.235x | -19.06% |
| 2019-12-31 | €139.44 Million | €40.43 Million | 0.290x | +69.34% |
| 2018-12-31 | €123.88 Million | €21.21 Million | 0.171x | -25.00% |
| 2017-12-31 | €117.52 Million | €26.83 Million | 0.228x | +26.71% |
| 2016-12-31 | €110.08 Million | €19.83 Million | 0.180x | +16.19% |
| 2015-12-31 | €104.67 Million | €16.23 Million | 0.155x | +37.54% |
| 2014-12-31 | €94.49 Million | €10.65 Million | 0.113x | -30.65% |
| 2013-12-31 | €90.27 Million | €14.68 Million | 0.163x | -- |